The Scavenger Receptor MARCO Expressed by Tumor-Associated Macrophages Are Highly Associated With Poor Pancreatic Cancer Prognosis
Macrophage-targeting therapies have become attractive strategies for immunotherapy. Deficiency of MARCO significantly inhibits tumor progression and metastasis in murine models of pancreatic cancer. However, the role of MARCO in patients with pancreatic cancer remains unclear. In the present study,...
Main Authors: | Bian Shi, Junfeng Chu, Tao Huang, Xiaoqian Wang, Qiujian Li, Qilong Gao, Qingxin Xia, Suxia Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.771488/full |
Similar Items
-
Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer
by: Bei Li, et al.
Published: (2020-10-01) -
High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer
by: Minna M. Jääskeläinen, et al.
Published: (2024-02-01) -
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
by: Clovis Boibessot, et al.
Published: (2022-01-01) -
Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma
by: Liva K. Stuhr, et al.
Published: (2023-01-01) -
Hyperglycemia Induces Inflammatory Response of Human Macrophages to CD163-Mediated Scavenging of Hemoglobin-Haptoglobin Complexes
by: Laura Matuschik, et al.
Published: (2022-01-01)